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Abstract: 
Objective: The objective of the study was to explain the ocular demonstrations of Stevens-Johnson Syndrome/Toxic 
epidermal necrolysis among restless patients at a tertiary care Hospital. 
Methods: This research study was conducted at Sir Ganga Ram Hospital, Lahore (February to December 2017), 
patients were detected with Stevens-Johnson Syndrome/Toxic epidermal necrosis. The information was assembled for 
these patients regarding age, gender, causes and ocular results. To analyses data statically, SPSS was employed. 
Results: Total patients selected for this study were 87. The number of male patients was 48 (55.2%). The age bracket 
for these patients was between 1 month to 84 years. The mean age was (33.2 ± 22.2) years. Idiopathic, non-steroidal 
inflammatory drugs and anti-epileptics were the common reasons. These reasons were observed in 20 (23%) and 11 
(12.6%) respectively. Because of minor conjunctival adhesions, glass Roding was carried out in 16 (18.4%) patients. 
Moreover, ocular involvement was observed in 45 (51.7%), genital-mucosal involvement was observed in 27 (31.0%) 
and mucosal participation was observed in 34 (96.6%) patients. 
Conclusion: There was a common ocular demonstration of different extremity. The most obvious cause was drugs. 
Keywords: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Ocular Manifestations, Etiology. 
Corresponding author:  
Dr. Ali Waqas, 
Medical Officer. 
 
 
 
 
Please cite this article in press Ali Waqas et al., An Assessment Of Ocular Etiological Factors, Complications And 
Manifestation Among Restless Toxic Epidermal Necrolysis/ Stevens-Johnson Syndrome Patients., Indo Am. J. P. 
Sci, 2019; 06(03). 
QR code 
 
 
IAJPS 2019, 06 (03), 4939-4942                       Ali Waqas et al                         ISSN 2349-7750 
 
 
w w w . i a j p s . c o m  
 
Page 4940 
INTRODUCTION: 
Stevens-Johnson Syndrome (SJS) is a disease related 
to immunology. Severe reside of the skin and 
participation of mucous membranes from urethral, 
ocular, nasal, vaginal and nasal indicate this disorder 
[1]. In 1922, Stevens and Johnson introduced this 
disorder. The extreme form of SJS is toxic epidermal 
necrosis (TEN). Approximately 30% of the body area 
is covered by this disorder [2]. Generally, all age 
groups and ethnic groups and both genders are affected 
by SJS and TEN. The annual occurrence of TEN (new 
cases per million people) is 0.4 to 1.2 and that of SJS 
is 1.2 to 7.0 [3, 4]. Non-steroidal anti-inflammatory 
drugs [NSAIDS], antibiotics, malignancies, 
anticonvulsants, drugs as allopurinol and infection are 
the main factors that contribute to this disorder. 
Idiopathy is involved in more than half of the cases. 
There is no clear information about the origin of this 
disorder [5, 6]. Even after avoiding the use of drugs, 
the time duration of the clinic is long. This long study 
is the foundation of treatment [7]. Majority of the 
ocular cases occur after or with the participation of 
skin. In nature, these results are very serious [8]. In 
South Asian countries along with Pakistan, the 
research studies regarding ocular demonstration of 
SJS/TEM among restless patients at a tertiary care 
Hospital. 
 
PATIENTS & METHODS: 
This research study was conducted at Sir Ganga Ram 
Hospital, Lahore (February to December 2017), 
patients were detected with Stevens-Johnson 
Syndrome/Toxic epidermal necrosis. The information 
was assembled for these patients regarding age, 
gender, causes of disorder and ocular results. Those 
patients were not selected for this study who were not 
selected for this study who were found with a record 
of previous ocular results. Those patients were not 
selected for this study who were found with a record 
of previous ocular issues. The comprehensive 
information about drugs is assembled. This helped in 
the evaluation of the frequency of every contributing 
factor. A proforma was designed. The information on 
type, demographics, factors causing SJS/TEN and 
seriousness of ocular complexities of ocular 
complexities was recorded on this proforma. For 
quantitative variables such as age, mean and standard 
deviation (SD) were calculated. To explain categorical 
variables, percentages and frequencies were measured. 
To analyse data statistically, SPSS was employed. 
 
RESULTS: 
Total patients enrolled for this study were 87. These 
patients were admitted to Hospital during the time of 
study and were suffering from SJS/TEN. The number 
of male and female patients were suffering from 
SJS/TEN. The number of male and female patients 
were 48 (55.2%) and 39 (44.8%) respectively. The age 
bracket for these patients was between 1 month to 84 
years. The mean age was (33.2 ± 2), 22.2 years. The 
median age of these patients was 36 years. The 
common factors contribute to this disorder were 
Idiopathy followed by NSAIDs, anti-epileptic 
fluoroquinolones, anti-malarial drugs, anti-gout 
medication and penicillin and cephalosporins. These 
factors are found with the percentage 20 (23%), 11 
(12.6%), 8 (9.2%), 7 (8.0%), 6 (6.9%) and 5 (5.7%) 
respectively. Because of minor conjunctival 
adhesions, glass Roding was carried out in 16 (18.4%) 
patients. Moreover, ocular involvement was observed 
in 45 (51.7%), genital-mucosal involvement was 
observed in 27 (31.0%) and mucosal participation was 
observed in 84 (96.6%) patients. The formation of 
ulcer was observed in 1 (1.14%). The ulcer was formed 
due to conjunctival adhesions were found in 2 (2.2%) 
patients. These patients developed these symptoms 
ever after the use of lubricants. 
 
Table: Symptoms Stratification 
 
Frequency Number Percentage 
Unknown 20 23 
NSAIDS 11 12.6 
Anti-epileptics 11 12.6 
Fluoroquinolones 8 9.2 
Antimalarial 7 8 
Anti-gout medication 6 6.9 
Penicillin 5 5.7 
Cephalosporin 5 5.7 
Metronidazole 3 3.4 
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Sulpha-containing drug 2 2.3 
Anti-tuberculosis drug 2 2.3 
Macrolides 2 2.3 
Anthelmintic agents 1 1.1 
Clarithromycin 1 1.1 
Acetaminophen 1 1.1 
Tetracycline 1 1.1 
Antifungal 1 1.1 
 
 
 
 
NSAIDs: Non-steroidal inflammatory drugs. 
SJS: Stevens-Johnson Syndrome 
TEN: Toxic Epidermal Necrosis. 
 
DISCUSSION: 
The goal of this study was to explain the ocular 
demonstrations of SJS/TEN among restless patients at 
a tertiary care Hospital. The ocular demonstrations 
were observed in about half the case of the study [9]. 
The ocular related complexities may be serious. The 
situation that endangered sight, like corneal 
scars/vascularization, may occur due to these 
complications. So, regular eye check-up is very 
necessary for these patients [10]. For the previous 
many years, management of ocular complexities of 
SJS remain the same initially, the surface of the eye is 
lubricated repeatedly. In our study, two patients were 
found with conjunctival adhesions and eye dryness. 
The eyes of these patients were lubricated with 
lubricants. Moreover, to manage conjunctival 
adhesions, glass Roding was carried out in 1 in 5 
patients. There was a difference in the metabolism of 
drug genetically. Also, the level of attention and care 
was different in patients. So, at presentation, the 
seriousness of ocular complexities may not be the 
same in different racial and ethnic groups [11]. 
Unluckily, especially in South East Asia, the 
information regarding aspects of SJS/TEN is not 
sufficient. There observed long-term participation of 
the eye. As a result, sight is sometimes endangered 
[12]. The patient should be aware of possible factors 
that contribute to the disorder. The most obvious factor 
of this disorder was drug in most cases in our study. 
Other factors such as antimalarials, penicillin, 
NSAIDs, fluoroquinolone’s, anti-gout medication, 
cephalosporin’s anti-epileptics also contribute to this 
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disorder. In the present, one-four of the cases could not 
find with particular an aetiology. 60% of SJS cases are 
due to drugs, as illustrated by many research studies 
[11, 13]. 
 
CONCLUSION: 
The study concluded that there were common ocular 
demonstrations of different extremity. The most 
obvious cause was drugs in our study. It can lead to 
long-term complexities. To decrease these 
complexities, demonstration in time. In order to 
understand and highlight possible factors that 
contribute to this disorder, it is important to organize 
more research studies. 
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